Compare SSRM & AORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SSRM | AORT |
|---|---|---|
| Founded | 1946 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Precious Metals | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.5B | 2.1B |
| IPO Year | 1996 | 1993 |
| Metric | SSRM | AORT |
|---|---|---|
| Price | $21.28 | $44.15 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 5 | 5 |
| Target Price | $21.89 | ★ $49.36 |
| AVG Volume (30 Days) | ★ 2.5M | 333.4K |
| Earning Date | 02-17-2026 | 02-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 1.05 | N/A |
| Revenue | ★ $1,431,099,000.00 | $422,646,000.00 |
| Revenue This Year | $57.69 | $15.97 |
| Revenue Next Year | $44.90 | $10.96 |
| P/E Ratio | $20.50 | ★ N/A |
| Revenue Growth | ★ 30.30 | 9.81 |
| 52 Week Low | $7.00 | $21.97 |
| 52 Week High | $25.98 | $48.25 |
| Indicator | SSRM | AORT |
|---|---|---|
| Relative Strength Index (RSI) | 42.75 | 40.08 |
| Support Level | $21.41 | $45.75 |
| Resistance Level | $22.50 | $48.00 |
| Average True Range (ATR) | 1.02 | 1.36 |
| MACD | -0.12 | -0.20 |
| Stochastic Oscillator | 14.21 | 9.43 |
SSR Mining Inc is a minerals company focused on mining precious metals in the Americas. More than half of Silver Standard's revenue is attributable to the production of gold, with a key portion derived from silver production. The company owns and operates the Marigold mine in Nevada, United States; the Seabee Gold Operation in Saskatchewan, Canada; and the Puna mine in Argentina. The majority of gold production is derived from the Marigold mine, and Silver Standard's silver production is principally derived from the Puna mine.
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.